全文获取类型
收费全文 | 148422篇 |
免费 | 32465篇 |
国内免费 | 2390篇 |
专业分类
耳鼻咽喉 | 5168篇 |
儿科学 | 5358篇 |
妇产科学 | 2364篇 |
基础医学 | 2970篇 |
口腔科学 | 1481篇 |
临床医学 | 26594篇 |
内科学 | 46906篇 |
皮肤病学 | 7426篇 |
神经病学 | 14704篇 |
特种医学 | 6329篇 |
外科学 | 40774篇 |
综合类 | 242篇 |
现状与发展 | 72篇 |
预防医学 | 6974篇 |
眼科学 | 3320篇 |
药学 | 924篇 |
中国医学 | 20篇 |
肿瘤学 | 11651篇 |
出版年
2024年 | 512篇 |
2023年 | 4801篇 |
2022年 | 1157篇 |
2021年 | 3089篇 |
2020年 | 6023篇 |
2019年 | 2148篇 |
2018年 | 7375篇 |
2017年 | 7326篇 |
2016年 | 8406篇 |
2015年 | 8382篇 |
2014年 | 15460篇 |
2013年 | 15577篇 |
2012年 | 5400篇 |
2011年 | 5427篇 |
2010年 | 10301篇 |
2009年 | 14205篇 |
2008年 | 5710篇 |
2007年 | 3954篇 |
2006年 | 6417篇 |
2005年 | 3693篇 |
2004年 | 2962篇 |
2003年 | 1935篇 |
2002年 | 2016篇 |
2001年 | 3782篇 |
2000年 | 2988篇 |
1999年 | 3192篇 |
1998年 | 3629篇 |
1997年 | 3450篇 |
1996年 | 3353篇 |
1995年 | 3193篇 |
1994年 | 1934篇 |
1993年 | 1557篇 |
1992年 | 1350篇 |
1991年 | 1399篇 |
1990年 | 1054篇 |
1989年 | 1171篇 |
1988年 | 1008篇 |
1987年 | 833篇 |
1986年 | 883篇 |
1985年 | 712篇 |
1984年 | 542篇 |
1983年 | 514篇 |
1982年 | 507篇 |
1981年 | 393篇 |
1980年 | 356篇 |
1979年 | 309篇 |
1978年 | 328篇 |
1977年 | 397篇 |
1975年 | 278篇 |
1972年 | 279篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
111.
Sandrine Hild MD MPH Marion Johanet MD Anna Valenza MD Maïna Thabaud MD Flore Laforest MD MPH Emilie Ferrat MD PhD Cédric Rat MD PhD for the DEDICACES Group the French National College of General Practitioners 《Cancer》2020,126(12):2765-2774
Mammographic screening contributes to a reduction in specific mortality, but it has disadvantages. Decision aids are tools designed to support people's decisions. Because these aids influence patient choice, their quality is crucial. The objective of the current study was to conduct a systematic review of decision aids developed for women eligible for mammographic screening who have an average breast cancer risk and to assess the quality of these aids. The systematic review included articles published between January 1, 1997, and August 1, 2019, in the PubMed, Embase, Cochrane, and PsycInfo databases. The studies were reviewed independently by 2 reviewers. Any study containing a decision aid for women eligible for mammographic screening with an average breast cancer risk was included. Two double-blind reviewers assessed the quality of the selected decision aids using the International Patient Decision Aid Standards instrument, version 3 (IPDASi). Twenty-three decision aids were extracted. Classification of decision aid quality using the IPDASi demonstrated large variations among the decision aids (maximum IPDASi score, 188; mean ± SD score, 132.6 ± 23.8; range, 85-172). Three decision aids had high overall scores. The 3 best-rated dimensions were disclosure (maximum score, 8; mean score, 6.8), focusing on transparency; information (maximum score, 32; mean score, 26.1), focusing on the provision of sufficient details; and probabilities (maximum score, 32; mean score 25), focusing on the presentation of probabilities. The 3 lowest-rated dimensions were decision support technology evaluation (maximum score, 8; mean score, 4.3), focusing on the effectiveness of the decision aid; development (maximum score, 24; mean score, 12.6), evaluating the development process; and plain language (maximum score, 4; mean score, 1.9), assessing appropriateness for patients with low literacy. The results of this review identified 3 high-quality decision aids for breast cancer screening. 相似文献
112.
113.
114.
115.
116.
117.
118.
119.